![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0437.jpg)
S422
ESTRO 36
_______________________________________________________________________________________________
plaques with radiochromic film, and all of them use
specifically machined plastic phantoms. We aimed to
develop a practical experimental method for measuring
the absolute absorbed dose distributions in water
produced by
106
Ru/
106
Rh plaques using the EBT3
radiochromic film.
Material and Methods
Two experimental setups were developed to measure dose
planes (1) perpendicular to the symmetry axis of the
plaque at 5 mm from the intersection of the symmetry axis
with the concave plaque surface, and (2) containing the
symmetry axis of the plaques (PDD planes). Both, the
plaque and the film, were immersed in water. The
required materials are easily affordable by a medical
physics department without the need of specifically
machined solid phantoms. The setups were tested
measuring dose distributions from one CCA and two CCX
plaques. Dose distributions were obtained from the
irradiated films using the triple-channel dosimetry
algorithm implemented in the FilmQA 2015 software. The
measured dose distributions were compared with the
results of Monte Carlo simulations run with the PENELOPE
code, and with published data.
Results
The measured absolute dose rates agreed with the values
quoted in the calibration certificates of the plaques within
the experimental uncertainty, with typical differences
below 5%. The relative standard uncertainties obtained
were of 3.8% for dose distributions measured at planes
perpendicular to the symmetry axis at 5 mm from the
surface of the plaque, and of 7.4% for planes containing
the symmetry axis. These values are comparable to those
reported by other authors using plastic phantoms, but
avoiding the uncertainties associated to the conversion
from dose–to–plastic to dose–to–water. A good agreement
was obtained between measurements and simulations,
improving upon published data (see figures for data of
depth-dose curves, and lateral profiles at 5 mm from the
surface of the plaque, for the CCX plaques).
Conclusion
We developed a practical experimental method to
measure with the EBT3 radiochromic film the dose
distributions in water produced by
106
Ru/
106
Rh ophthalmic
plaques. The obtained results were of similar or better
quality than those obtained using solid phantoms. These
setups may ease the quality assurance procedures to the
users of these plaques.
PO-0794 Comprehensive quality assurance test for high
precision teletherapy
S. Wegener
1
, A. Spiering
1
, O.A. Sauer
1
1
University Hospital, Radiation Oncology, Würzburg,
Germany
Purpose or Objective
Modern radiation therapy aims to minimize negative side
effects on healthy tissue by tailoring the dose distribution
as accurately as possible to each individual tumor. This
leads to a progressively increasing complexity of the
treatment plans and demands a very high precision of all
involved components. Even small errors can significantly
compromise treatment techniques which require such an
extensive precision as stereotactic radiation therapy. A
suitable quality management for such techniques should
include a regular end-to-end test that closely mimics the
entire procedure of the actual patient treatment while
being able to reliably detect a variety of possible errors